T0	Participants 79 95	type 2 diabetes.
T1	Participants 293 322	patients with type 2 diabetes
T2	Participants 454 478	type 2 diabetic patients
T3	Participants 617 710	eight patients with type 2 diabetes who were being treated with oral glucose-lowering agents.
T4	Participants 1985 2009	type 2 diabetic patients
T5	Participants 2471 2515	atherosclerosis in type 2 diabetic patients.